Jacobi Capital Management’s Globus Medical GMED Stock Holding History

Jacobi Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30	Closed	-$2K	–	1393
2020 Q4	$2K	Hold	30	–	–	﹤0.01%	1156
2020 Q3	$1K	Hold	30	–	–	﹤0.01%	1177
2020 Q2	$1K	Hold	30	–	–	﹤0.01%	1139
2020 Q1	$1K	Buy	+30	New	+$1.48K	﹤0.01%	1042
2019 Q3	–	Sell	-106	Closed	-$4K	–	1065
2019 Q2	$4K	Hold	106	–	–	﹤0.01%	862
2019 Q1	$5K	Hold	106	–	–	﹤0.01%	785
2018 Q4	$5K	Hold	106	–	–	﹤0.01%	750
2018 Q3	$6K	Hold	106	–	–	﹤0.01%	765
2018 Q2	$5K	Hold	106	–	–	﹤0.01%	817
2018 Q1	$5K	Hold	106	–	–	﹤0.01%	801
2017 Q4	$5K	Hold	106	–	–	﹤0.01%	770
2017 Q3	$3K	Hold	106	–	–	﹤0.01%	796
2017 Q2	$3K	Hold	106	–	–	﹤0.01%	721
2017 Q1	$3K	Buy	+106	New	+$2.89K	﹤0.01%	592
2016 Q4	–	Sell	-106	Closed	-$2K	–	641
2016 Q3	$2K	Hold	106	–	–	﹤0.01%	641
2016 Q2	$3K	Buy	+106	New	+$2.54K	﹤0.01%	593

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Jacobi Capital Management's GMED Position: Q1 2021 in Review

Jacobi Capital Management sold out of Globus Medical (GMED) in Q1 2021, closing a stake of 30 shares — an estimated $2K sold.

Jacobi Capital Management first reported a position in GMED in Q2 2016 and held it in 16 quarters. The position peaked at $6K in Q3 2018. 345 funds tracked by Wall St. Rank hold GMED as of Q1 2021.

Jacobi Capital Management reported no remaining Globus Medical position as of Q1 2021 after selling out during the quarter.
Jacobi Capital Management sold 30 Globus Medical shares in Q1 2021, an estimated $2K.
Jacobi Capital Management first reported a position in Globus Medical in Q2 2016 and held it in 16 quarters.
Jacobi Capital Management's Globus Medical position peaked at $6K in Q3 2018.
345 funds tracked by Wall St. Rank held Globus Medical as of Q1 2021.

Based on Jacobi Capital Management's 13F filing for Q1 2021, filed 11 May 2021.